Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
Kavinderjit Nanda, Alan C MossCenter for Inflammatory Bowel Disease, BIDMC/Harvard Medical School, Boston, MA, USAAbstract: Ulcerative colitis (UC) is a chronic inflammatory disease of the colon that typically manifests as diarrhea, abdominal pain, and bloody stool. Complications, such as colorectal...
Guardado en:
Autores principales: | Nanda K, Moss AC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/700ef8beae274ebe9effe74d841de870 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
por: Nanda K, et al.
Publicado: (2013) -
Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi G, et al.
Publicado: (2021) -
Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis
por: Peishan Qiu, et al.
Publicado: (2021) -
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)
por: Bartosh NS, et al.
Publicado: (2013) -
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Halka K, et al.
Publicado: (2011)